ZIMMER BIOMET HLDGS DL-01
ZIMMER BIOMET HLDGS DL-01/ US98956P1021 /
ZIM
|
07.11.2024 07:57:05
|
Zm.
+0,1500
|
Wolumen |
Bid09:39:17 |
Ask09:39:17 |
Kapitalizacja Rynkowa |
St. dywidendy |
Wskaźnik C/Z |
|
102,6500EUR
|
+0,15%
|
-
Obrót: - |
101,9500Wolumen Bid: 60 |
102,9000Wolumen Ask: 60 |
20,43 mldEUR |
- |
- |
Opis działalności
Founded in 1927 and headquartered in Warsaw, Indiana, USA, Zimmer Biomet is a global leader in musculoskeletal healthcare. The company designs, manufactures and markets orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products.
Zarząd & Rada nadzorcza
| CEO |
| Ivan Tornos |
| Zarząd |
| Suketu Upadhyay, Mark Bezjak, Rachel Ellingson, Nitin Goyal, David J. Kunz, Angela Main, Keri P. Mattox, Chad Phipps, Paul Stellato, Zeeshan Tariq, Kenneth R. Tripp, Lori Winkler, Sang Yi, Wilfred van Zuilen |
| Rada nadzorcza |
| Christopher B. Begley, Betsy J. Bernard, Michael J. Farrell, Robert A. Hagemann, Ivan Tornos, Arthur J. Higgins, Maria Teresa Hilado, Syed Jafry, Sreelakshmi Kolli, Michael W. Michelson |
Dane firmy
| Nazwa: |
Zimmer Biomet Holdings Inc. |
| Adres: |
345 East Main Street,Warsaw, Indiana 46580, USA |
| Telefon: |
+1-574-373-3121 |
| Fax: |
- |
| E-mail: |
surveys@zimmerbiomet.com
|
| Internet: |
www.zimmerbiomet.com/ |
| Przemysł: |
Służba zdrowia |
| Sektor: |
Produkty Medyczne |
| Podsektor: |
Zaawansowane Urządzenia Medyczne |
| Koniec roku finansowego: |
31.12 |
| Free float: |
74,90% |
| Data IPO: |
03.08.2001 |
Główni akcjonariusze
| Inne |
|
52,20% |
| Vanguard Group Inc |
|
11,59% |
| BlackRock Inc. |
|
9,09% |
| Dodge & Cox |
|
5,57% |
| Price T Rowe Associates Inc Md |
|
4,58% |
| State Street Corporation |
|
4,52% |
| Invesco Ltd. |
|
3,01% |
| American Century Companies Inc |
|
2,88% |
| Primecap Management Co Ca |
|
2,47% |
| Inne |
|
4,09% |
